Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus

Epilepsia

Volumn 50, Issue 3, 2009, Pages 415-421

  Uges, Joris W F ^a,b   Van Huizen, Marc D ^a   Engelsman, Jeroen ^a   Wilms, Erik B ^a,b   Touw, Daniel J ^b   Peeters, Els ^a   Vecht, Charles J ^a  

^a MEDICAL CENTER HAAGLANDEN   (Netherlands)

^b Central Hospital Pharmacy   (Netherlands)

Author keywords

Levetiracetam; Pharmacokinetics; Safety; Status epilepticus

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE; CLONAZEPAM; DIAZEPAM; ETIRACETAM; MIDAZOLAM; PHENYTOIN; PROPOFOL; THIOPENTAL; VALPROIC ACID;

ADD ON THERAPY; ADULT; AGED; ALCOHOLISM; ANTICONVULSANT THERAPY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMPARTMENT MODEL; CONTINUOUS INFUSION; DEMENTIA; DISEASE DURATION; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG SAFETY; EPILEPTIC STATE; FACE ERYTHEMA; FEMALE; FLUSHING; FOLLOW UP; GLIOBLASTOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOCALCEMIA; HYPOMAGNESEMIA; HYPONATREMIA; INJECTION SITE REACTION; LOADING DRUG DOSE; MALE; MENINGOENCEPHALITIS; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPEATED DRUG DOSE; SIDE EFFECT; SINGLE DRUG DOSE; STROKE; SUBDURAL HEMATOMA; TREATMENT RESPONSE;

ADULT; AGED; ANTICONVULSANTS; BAYES THEOREM; BIOLOGICAL AVAILABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; DRUG TOXICITY; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PIRACETAM; PROSPECTIVE STUDIES; STATUS EPILEPTICUS;

EID: 61849142679     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2008.01889.x     Document Type: Article

References (32)

1. Aldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, Gottwald MD, O'Neil N, Neuhaus JM, Segal MR, Lowenstein DH 2001) Comparison of lorazepam, diazepam and placebo for the treatment of out-hospital status epilepticus. N Engl J Med 345 : 631 637.
2. Baulac M, Brodie MJ, Elger CE, Krakow K, Stockis A, Meyvisch P, Falter U 2007) Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures. Epilepsia 48 : 589 592.
3. Berkovic SF, Knowlton RC, Leroy RF, Schiemann J, Falter U 2007) Levetiracetam N01057 Study Group Placebo - controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 69 : 1751 1760.
4. Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ Levetiracetam Monotherapy Study Group 2007) Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 68 : 402 408.
5. Chen JWY, Naylor DE, Wasterlain CG 2007) Advances in the pathophysiology of status epilepticus. Acta Neurol Scand 115 : S7 S15.
6. Eriksson K, Metsäranta P, Huhtala H, Auyinen A, Kuusela AL, Koivikko M 2005) Treatment delay and the risk of prolonged status epilepticus. Neurology 65 : 1316 1318.
7. Farooq MU, Naravetla B, Majid A, Gupta R, Pysh JJ, Kassab MY 2007) IV levetiracetam in the management of non-convulsive status epilepticus. Neurocrit Care 7 : 36 39.
8. Gibbs JE, Walker MC, Cock HR 2006) Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus. Epilepsia 47 : 469 478.
9. Glien M, Brandt C, Potschka H, Loscher W 2002) Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in rat pilocarpine model of temporal lobe epilepsy. Epilepsia 43 : 350 357.
10. Knake S, Gruener J, Hattemer K, Klein KM, Bauer S, Oertel H, Hamer HM, Rosenow F 2008) Intravenous levetiracetam in the treatment of benzodiazepine-refractory status epilepticus. J Neurol Neurosurg Psychiatry 79 : 588 589.
11. Lowenstein DH, Blecl T, Macdonald RL 1999) It's time to revise the definition of status epilepticus. Epilepsia 40 : 120 122.
12. Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B 2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A 101 : 9861 9866.
13. Mazarati AM, Baldwin R, Klitgaard H, Matagne A, Wasterlain CG 2004) Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus. Epilepsy Res 58 : 167 174.
14. Noachtar S, Andermann E, Meyvisch P, Andermann F, Gough WB, Schiemann-Delgado J N166 Levetiracetam Study Group 2008) Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 70 : 607 616.
15. Patel N, Landan I, Levin J, Szaflarski J, Wilner A 2006) The use of levetiracetam in refractory status epilepticus. Seizure 15 : 137 141.
16. Patsalos PN 2004) Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet 43 : 707 724.
17. Prasad K, Al-Roomi K, Krishnan PR, Sequeira R 2005) Anticonvulsant therapy for status epilepticus. Cochrane Database Syst Rev Oct 19 4 CD003723.
18. Ramael S, de Smedt F, Toublanc N, Otoul C, Boulanger P, Riethuisen J-M, Stockis A 2006a) Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multi-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects. Clin Ther 28 : 734 744.
19. Ramael S, Daoust A, Otoul C, Toublanc N, Troenaru M, Lu Z, Stockis A 2006b) Levetiracetam intravenous infusion: a randomized placebo-controlled safety and pharmacokinetic study. Epilepsia 47 : 1128 1135.
20. Rigo J-M, Hans G, Nguyen L, Rocher V, Belachew S, Malgrange B, Leprince P, Moonen G, Selak I, Matagne A, Klitgaard H 2002) The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. Br J Pharmacol 136 : 659 667.
21. Rosenow F, Arzimanoglou A, Baulac M 2002) Recent developments in treatment of status epilepticus: a review. Epileptic Disord 4 : S41 S51.
22. Rossetti AO, Bromfield EB 2005) Levetiracetam in the treatment of status epilepticus in adults: a study of 13 episodes. Eur Neurol 54 : 34 38.
23. Rupprecht S, Franke K, Fitzek S, Witte O, Hagemann G 2007) Levetiracetam as a treatment option in non-convulsive status epilepticus. Epilepsy Res 73 : 238 244.
24. Schultz-Bonhage A, Hefft S, Oehl B 2007) Termination of complex partial status epilepticus by intravenous levetiracetam - a case report. J Neurol Neurosurg Psychiatry Published online: 12-Mar-2007: doi :.
25. Shorvon SD 1993) Tonic-clonic status epilepticus. J Neurol Neurosurg Psychiatry 56 : 125 134.
26. Shorvon SD 2001) The management of status epilepticus. J Neurol Neurosurg Psychiatry 70 : II22 II27.
27. Shorvon SD, Lowenthal A, Janz D, Bielen E, Loiseau PO 2000) Multicenter double-blind, randomised, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures: European Levetiracetam Study Group. Epilepsia 41 : 1179 1186.
28. Snoeck E, Jacqmin P, Sargentini-Maier ML, Stockis A 2007) Modeling and simulation of intravenous levetiracetam pharmacokinetic profiles in children to evaluate dose adaptation rules. Epilepsy Res 76 : 140 147.
29. Treiman DM, Meyers PD, Wltron NY, Collins JF, Colling C, Rowman AJ, Handforth A, Faught E, Calabrese VP, Uthman BM, Ramsay RE, Mamdani MB 1998) A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 339 : 792 798.
30. Uges J, LeBrun P, Touw D 2007) Compatibility of levetiracetam (Keppra) and clonazepam (Rivotril) solutions for injection. Epilepsia 48 : S109 (Abstract).
31. Wetzels JF, Kiemeney LA, Swinkels DW, WIllems HL, den Heijer M 2007) Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int 72 : 632 637.
32. Yan H, Ji-qun C, Ishihara K, Nagayama T, Serikawa T, Sasa M 2005) Separation of antiepileptogenic and antiseizure effect of levetiracetam in spontaneously epileptic rat (SER). Epilepsia 46 : 1170 1177.